Equities Research Analysts’ Upgrades for March 24th (ALNY, BA, CAPL, CHH, CYRX, FDX, GPRO, LITE, MATV, NOV)

Equities Research Analysts’ upgrades for Monday, March 24th:

Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $328.00 target price on the stock, up from their previous target price of $280.00.

Boeing (NYSE:BA) was upgraded by analysts at Melius from a hold rating to a buy rating.

CrossAmerica Partners (NYSE:CAPL) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Choice Hotels International (NYSE:CHH) was upgraded by analysts at Redburn Atlantic from a sell rating to a neutral rating. The firm currently has $132.00 price target on the stock.

Cryoport (NASDAQ:CYRX) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $10.00 target price on the stock.

FedEx (NYSE:FDX) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. Jefferies Financial Group Inc. currently has $275.00 target price on the stock, down from their previous target price of $300.00.

GoPro (NASDAQ:GPRO) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Lumentum (NASDAQ:LITE) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. Raymond James currently has $82.00 target price on the stock, down from their previous target price of $96.00.

Mativ (NYSE:MATV) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. They currently have $10.00 target price on the stock, down from their previous target price of $15.50.

NOV (NYSE:NOV) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has $22.00 target price on the stock.

Nucor (NYSE:NUE) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have $160.00 target price on the stock, up from their previous target price of $156.00.

Nexalin Technology (NASDAQ:NXL) was upgraded by analysts at Maxim Group from a hold rating to a buy rating. They currently have $5.00 target price on the stock.

Ovintiv (NYSE:OVV) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. BMO Capital Markets currently has $57.00 price target on the stock, up from their previous price target of $55.00.

Peyto Exploration & Development (TSE:PEY) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. They currently have C$19.50 price target on the stock, up from their previous price target of C$18.50.

Pinterest (NYSE:PINS) was upgraded by analysts at Guggenheim from a neutral rating to a buy rating. The firm currently has $40.00 price target on the stock, up from their previous price target of $39.00.

Steel Dynamics (NASDAQ:STLD) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have $149.00 price target on the stock.

Valley National Bancorp (NASDAQ:VLY) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. The firm currently has $11.00 price target on the stock.

Viasat (NASDAQ:VSAT) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. They currently have $15.00 price target on the stock.

Wyndham Hotels & Resorts (NYSE:WH) was upgraded by analysts at Redburn Atlantic from a neutral rating to a buy rating. They currently have $115.00 price target on the stock.

Receive News & Ratings for Alnylam Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.